ML23249A172
| ML23249A172 | |
| Person / Time | |
|---|---|
| Site: | 07109398 |
| Issue date: | 08/28/2023 |
| From: | Ashley Ferguson Croft Associates Limited |
| To: | William Allen Storage and Transportation Licensing Branch |
| References | |
| Download: ML23249A172 (1) | |
Text
Croft Associates Ltd F4 Culham Science Centre Culham, Abingdon, Oxon, United Kingdom OX14 3DB Registered in England No: 1698337 T:
F:
E:
W:
+44 (0)1865 407740
+44 (0)1865 407449 info@croftltd.com www.croftltd.com FM 28718 - ISO9001 EMS 720456 - ISO14001 Page 1 of 2 28 August, 2023 Attention: William Allen Project Manager Licensing Branch Division of Spent Fuel Storage and Transportation Office of Nuclear Material Safety and Safeguards US Nuclear Regulatory Commission Washington DC 20555-0001 Docket No. 07109398 TAC No.
Subject:
Withdrawal of SARP 3997B Application for Shine Medical Mo-99 Contents Dear Mr. Allen Please accept this communication as our formal request to temporarily withdraw this application.
The application is being withdrawn due to delays and funding availability related to completion of the Mo-99 experimental work required to confirm the hydrogen and pressure generation details relating to the Shine Medical facilities production of Mo-99. However, if you require further information regarding this request, please contact:
Alex Ferguson Telephone: 00 44 1865 407740 Email: alex.ferguson@croftltd.com Address: Croft Associates Ltd, F4 Culham Science Centre, Culham, Abingdon, Oxfordshire. OX14 3DB, UK Yours sincerely Alex Ferguson Licensing Director Croft Associates Limited
[3977B-2023-08-SARP Rev0-Transmittal Letter-withdrawal.docx]
Croft Associates Ltd F4 Culham Science Centre Culham, Abingdon, Oxon, United Kingdom OX14 3DB Registered in England No: 1698337 T:
F:
E:
W:
+44 (0)1865 407740
+44 (0)1865 407449 info@croftltd.com www.croftltd.com FM 28718 - ISO9001 EMS 720456 - ISO14001 Page 2 of 2 Documents submitted Filename Document 3977B-2023-08-SARP Rev0-Transmittal Letter-withdrawal.pdf Transmittal Letter Shine 3977B Affidavit August 2023.pdf AFFIDAVIT PURSUANT TO 10 CFR 2.390